New Coronavirus (COVID-19) Antibody Test Can Help Determine Past COVID Infection

Eurofins Scientific’s (Luxembourg) US clinical diagnostics network is offering blood-based antibody testing for Coronavirus SARS-CoV-2 that can identify people who were exposed, may have developed some level of immunity to COVID-19 but potentially had mild to no symptoms. Eurofins' network will initially run nearly 5,000 tests per day, or 200 results every hour, helping first responders and healthcare providers. Over time, Eurofins' antibody testing can also help experts understand how much of the population has been infected with Coronavirus SARS-CoV-2.

Eurofins, through its subsidiaries, offers food, environmental, pharmaceutical and cosmetics products testing and in agroscience CRO services. It also provides certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. In addition, Eurofins is one of the leading global emerging players in esoteric clinical diagnostic testing. With over 47,000 staff across a network of more than 900 independent companies in over 50 countries generally specialized by end client markets and operating more than 800 laboratories, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services.


Eurofins has also launched proprietary, active infection testing through laboratories including Viracor Eurofins and Eurofins Diatherix using polymerase chain reaction (PCR) testing. Both laboratories have available capacity for additional PCR testing with same or next day results.

Related Links:
Eurofins Scientific